Scott Dreyer - 09 Jan 2023 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Role
EVP & Chief Commercial Officer
Signature
/s/ Colleen Tupper as Attorney-In-Fact For Joseph Ciaffoni
Issuer symbol
COLL
Transactions as of
09 Jan 2023
Net transactions value
-$488,554
Form type
4
Filing time
11 Jan 2023, 15:06:03 UTC
Previous filing
13 Jul 2022
Next filing
14 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock Sale $282,282 -10,424 -8.6% $27.08 110,208 09 Jan 2023 Direct F1, F2
transaction COLL Common Stock Sale $204,300 -7,341 -6.7% $27.83 102,867 09 Jan 2023 Direct F1, F3
transaction COLL Common Stock Sale $1,972 -69 -0.07% $28.58 102,798 09 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2022.
F2 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.49 to $27.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).
F3 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.49 to $28.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).